Saint Louis University
19 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
9
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 13 to 25, 2026 · next Dec 13
- 1 fee due Jan 21, 2027The maintenance fee for Beta amino acid derivatives as integrin antagonists (US 9,085,606) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
- 1 fee due Feb 20, 2027The maintenance fee for Dinaphthothiophene compounds (US 10,385,035) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
- 4 fees due Mar 5 to 29, 2027 · next Mar 5
- 1 fee due Apr 24, 2027The maintenance fee for Modulators of the estrogen-related receptor (US 11,795,162) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
- 2 fees due May 5 to 12, 2027 · next May 5
- 2 fees due Jun 19 to 30, 2027 · next Jun 19
- 2 fees due Aug 6 to 23, 2027 · next Aug 6
- 3 fees due Sep 3 to 5, 2027 · next Sep 3
- 3 fees due Oct 9 to 30, 2027 · next Oct 9
Recent changes
- 1 of the patents on this record was granted since Aug 22, 2026
- Nov 17 US 12,801,717 Systems and Methods for Two-Factor Authentication Using Vibration
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,299,018 | Proteins with an Attached Short Peptide of Acidic Amino Acids In force · Medium confidence | In force | Medium confidence | |
| US 8,691,208 | Compositions and methods for treating hypophosphatasia In force · USPTO record | In force | USPTO record | |
| US 7,871,624 | Chimeral polypeptide composition for cross-placenta delivery In force · USPTO record | In force | USPTO record | |
| US 8,784,833 | Prenatal enzyme replacement therapy for hypophosphatasia In force · USPTO record | In force | USPTO record | |
| US 9,963,450 | A3 Adenosine Receptor Agonists In force · Medium confidence | In force | Medium confidence | |
| US 8,110,655 | Method to promote hair growth and/or delay or treat hair loss by administering a TGF-β antagonist or inhibitor In force · USPTO record | In force | USPTO record | |
| US 7,972,593 | Delivery of therapeutic agents to the bone In force · USPTO record | In force | USPTO record | |
| US 8,946,201 | Methods for Inhibiting Tgf-Beta In force · High confidence | In force | High confidence | |
| US 9,011,820 | Screening tool for antiviral agents In force · USPTO record | In force | USPTO record | |
| US 9,040,287 | Molecular Biosensors Capable of Signal Amplification In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 75: 19 patents in force now held by others · 69 lapsed for an unpaid fee · 22 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
18 pending · 15 abandoned · 62 no status recorded